Literature DB >> 3031827

Parasexual analysis of human pepsinogen molecular heterogeneity.

R T Taggart, T K Mohandas, G I Bell.   

Abstract

Pepsinogens (PGA) are the inactive precursors of pepsin, the major acid protease found in the stomach. Highly polymorphic variation of these proteins has been demonstrated in several populations, and comparison of the DNA restriction fragment patterns obtained from informative pepsinogen phenotypes suggest that the polymorphism results from chromosomal haplotypes containing variable numbers of pepsinogen genes. In order to isolate the three most common PGA haplotypes (A, B, and C) and to unambiguously demonstrate their relationship to the observed protein heterogeneity, we constructed mouse X human somatic cell hybrids from individuals heterozygous for PGA and INS (insulin). Here, we describe analysis of hybrid cell lines that segregated human chromosomes containing the PGA genes and thereby provided for the parasexual discrimination of the different haplotypes on chromosome 11 determining the corresponding heterozygous phenotypes. These studies demonstrate that the A, B, and C haplotypes contain three, two, and one PGA genes, respectively. This unusual polymorphism of genomic DNA encoding very similar proteins probably reflects recent evolution by gene duplication.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031827     DOI: 10.1007/BF01534696

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  3 in total

1.  Family and population studies on the human pepsinogen A multigene family.

Authors:  J P Bebelman; M P Evers; B Zelle; R Bank; J C Pronk; S G Meuwissen; W H Mager; R J Planta; A W Eriksson; R R Frants
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

2.  Human pepsinogen A (PGA): an informative gene complex located at 11q13.

Authors:  F H Boudi; R A Lothe; R T Taggart
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

3.  Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

Authors:  J Mackay; P A Elder; D J Porteous; C M Steel; R A Hawkins; J J Going; U Chetty
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.